Molecular and cellular characterization of ABCG2 in the prostate

被引:48
|
作者
Pascal L.E. [1 ,2 ]
Oudes A.J. [1 ,2 ]
Petersen T.W. [2 ]
Goo Y.A. [1 ,2 ]
Walashek L.S. [1 ,2 ]
True L.D. [3 ]
Liu A.Y. [1 ,2 ]
机构
[1] Department of Urology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle
[2] Institute for Systems Biology, Seattle
[3] Department of Pathology, University of Washington, Seattle
关键词
Side Population; Hank Balance Salt Solution; Side Population Cell; Prostate Stem Cell Antigen; Basal Epithelium;
D O I
10.1186/1471-2490-7-6
中图分类号
学科分类号
摘要
Background. Identification and characterization of the prostate stem cell is important for understanding normal prostate development and carcinogenesis. The flow cytometry-based side population (SP) technique has been developed to isolate putative adult stem cells in several human tissue types including the prostate. This phenotype is mainly mediated by the ATP-binding cassette membrane transporter ABCG2. Methods. Immunolocalization of ABCG2 was performed on normal prostate tissue obtained from radical prostatectomies. Normal human prostate SP cells and ABCG2(+ )cells were isolated and gene expression was determined with DNA array analysis and RT-PCR. Endothelial cells were removed by pre-sorting with CD31. Results. ABCG2 positive cells were localized to the prostate basal epithelium and endothelium. ABCG2(+ )cells in the basal epithelium constituted less than 1% of the total basal cell population. SP cells constituted 0.5-3% of the total epithelial fraction. The SP transcriptome was essentially the same as ABCG2(+ )and both populations expressed genes indicative of a stem cell phenotype, however, the cells also expressed many genes in common with endothelial cells. Conclusion. These results provide gene expression profiles for the prostate SP and ABCG2(+ )cells that will be critical for studying normal development and carcinogenesis, in particular as related to the cancer stem cell concept. © 2007 Pascal et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] Characterization of zebrafish ABCG2 homologs
    Thomas, J. R.
    Robey, R.
    Frye, W.
    Inglut, C.
    Warner, A.
    Butcher, D.
    Matta, J.
    Edmondson, E.
    Gottesman, M.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 1117 - 1118
  • [2] Identification and characterization of ABCG2 enhancer regions
    Eclov, Rachel J.
    Ahituv, Nadav
    Kroetz, Deanna L.
    DRUG METABOLISM REVIEWS, 2011, 43 : 116 - 116
  • [3] The Efflux Transporter ABCG2 Maintains Prostate Stem Cells
    Sabnis, Neha G.
    Miller, Austin
    Titus, Mark A.
    Huss, Wendy J.
    MOLECULAR CANCER RESEARCH, 2017, 15 (02) : 128 - 140
  • [4] Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
    Stacy, Alexandra E.
    Jansson, Patric J.
    Richardson, Des R.
    MOLECULAR PHARMACOLOGY, 2013, 84 (05) : 655 - 669
  • [5] ABCG2 expressing prostate cancer cells regenerate prostate tumors in vivo
    Mathew, Grinu
    Timm, Earl
    Karasik, Ellen
    Montecinos, Viviana
    Smith, Gary
    Foster, Barbara
    Huss, Wendy
    CANCER RESEARCH, 2008, 68 (09)
  • [6] ABCG2: the molecular mechanisms of urate secretion and gout
    Woodward, Owen M.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 309 (06) : F485 - F488
  • [7] ABCG2: A perspective
    Robey, Robert W.
    To, Kenneth K. K.
    Polgar, Orsolya
    Dohse, Marius
    Fetsch, Patricia
    Dean, Michael
    Bates, Susan E.
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (01) : 3 - 13
  • [8] Biliary excretion and pharmacokinetics of ABCG2 substrates in Abcg2 knockout rats
    Huang, Liyue
    Be, Xuhai
    Colletti, Adria
    Roberts, John
    Langley, Meghan
    Lin, Min-Hwa J.
    Zhao, Zhiyang
    Wong, Bradley K.
    Jin, Lixia
    DRUG METABOLISM REVIEWS, 2011, 43 : 191 - 192
  • [9] Assessing the ABCG2 Protein Interactome: a Potential Strategy to Disrupt ABCG2 Function
    McHarg, Ailsa
    Gose, Tomoka
    Schuetz, John
    FASEB JOURNAL, 2020, 34
  • [10] Pharmacogenomic importance of ABCG2
    Cusatis, George
    Sparreboom, Alex
    PHARMACOGENOMICS, 2008, 9 (08) : 1005 - 1009